AEON Biopharma, Inc.

AEON Healthcare Biotechnology

In the quarter to June 2026, EPS grew 96.7%, free cash flow fell 76.9% and total debt fell 88.4%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

0.23 0.01 −4.17%
Market cap
$12.1M
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a
Dec '17 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Current Ratio
— 0.31 1.00 0.12 0.48 0.11 0.49
Net Debt/EBITDA
— (5.53) 0.26 (2.51) 0.01 0.16 (2.48)
Debt/Assets
0.00% 47.65% 0.00% 1,218.15% 0.00% 372.02% 622.30%
Debt/Equity
— 1.80 0.00 (0.49) 0.00 (0.41) (0.63)
Asset Turnover
— 0.00 0.00 0.00 0.00 0.00 0.00
Operating CF/Net income
— 0.00 (0.18) 0.68 0.12 (0.48) 0.44
Capex/Depreciation
— — — (4.50) 0.00 0.00 (0.05)
ROE
— 0.00% (97.00%) 36.58% 181.66% (46.26%) 93.84%
ROA
— (8.89%) 5.92% (36.53%) (4,365.11%) 841.19% (901.45%)
ROIC
— (5.45%) 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
— 8.80% 1,366,800.00% 72.69% 5,921.97% (340.84%) 1,175.37%
Research and Development Expense of Revenue
— — — 0.00% 0.00% 0.00% —
Selling, General and Administrative Expense of Revenue
— 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Intangible Assets out of Total Assets
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Share Based Compensation of Revenue
— — — 0.00% 0.00% 0.00% 0.00%
Free Cash Flow per Share
— 0.00 (15.80) (18.60) (92.68) (37.58) (1.74)
Cash per Share
— 0.22 5.26 5.05 10.00 0.02 0.30
Shareholders Equity per Share
— 0.26 (178.96) (140.11) (296.60) (52.91) (5.55)
Interest Debt per Share
— 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
— 0.26 (178.96) (140.11) (296.60) (52.91) (5.55)
Free Cash Flow
— — (1.49) (35.89) (47.82) (20.29) (17.31)
Working Capital
— (0.04) 0.00 (72.74) (6.83) (12.56) (3.50)
Capital Expenditures
— — — (0.31) — — 0.00
Net Current Asset Value
— (0.04) (293.04) (271.35) (153.67) (30.12) (57.19)
Other line items
Quick Ratio
— 0.31 0.60 0.12 0.40 0.00 0.44
Depreciation/Fixed assets
— — — 0.16 0.30 0.41 0.48
Cash ROIC
— 0.00% 9.10% 27.74% 32.34% 120.31% 99.37%
Accounts Payable Turnover
— 0.00 0.00 0.00 0.00 0.00 0.00
Average Days of Payables
— 0.00 0.00 0.00 0.00 0.00 0.00
Revenue per Share
— 0.00 0.00 0.00 0.00 0.00 0.00
Operating CF per Share
— 0.00 (15.80) (18.44) (92.68) (37.58) (1.74)
Capex per Share
— 0.00 0.00 (0.16) 0.00 0.00 0.00
Average Payables
— 0.33 0.33 4.22 5.60 4.65 3.43
Average Assets
— 0.04 138.52 143.86 8.81 4.99 4.35
Average Common Equity
— 129.55 (8.45) (143.67) (211.73) (90.81) (41.80)
Capex to Sales
— — — 0.00 — — 0.00

Fold the line items

Columns are period end dates